Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will take place at Toronto’s University Health Network (UHN) and Braxia’s CRTCE Research Clinic Largest study of its kind with IV Ketamine to be conducted in people living with bipolar disorder, a leading cause of […]
A 1-hour treatment with a low concentration of nitrous oxide, commonly known as “laughing gas,” appears to relieve symptoms of treatment-resistant major depression (TRMD), with effects lasting as long as several weeks, new research suggests. In a trial with a crossover design, investigators randomly assigned 28 patients with severe TRMD to receive a single 1-hour
Low-Dose Nitrous Oxide Shows Benefit for Resistant Depression Read More »
New research suggests lamotrigine could be a viable option in treating acute bipolar depression. A team, led by Evyn M. Peters, Department of Psychiatry, University of Saskatchewan, analyzed the efficacy of lamotrigine compared to placebo for the treatment of acute bipolar depression and determined if certain depression scale items were more responsive to lamotrigine treatment.
Analysis Shows Lamotrigine Effective Treating Acute Bipolar Depression Read More »
Similar to people, mice that consume a high-fat diet not only become obese, but also tend to be anxious and depressed. Scientific research backs up this observation as it has found that obesity and mental disorders such as depression and anxiety seem to often go hand in hand. Overnutrition leads to obesity, which tends to
Repairing altered novel brain circuit could tackle coinciding obesity and depression Read More »
Tropical Depression likely this weekend as system moves north today, impacts for Gulf Coast Friday Updated: 9:02 AM CDT Jun 17, 2021 Hide Transcript Show Transcript DAMON: LOOKING PRETTY GOOD IN ETH SOUTHEAST LOUISIANA SO FAR THIS MORNING. OVERALL, D AECENT DAY, BUT LET ME TAKE YOU TO THE TROPICS AND GIVE YOU ANOTHER LOOK
In this episode of CME’s podcast Rounding@IOWA, host Gerry Clancy, MD, and guest Aislinn Williams, MD, PhD, discuss the many variations of clinical depression and how that affects treatment planning. CME Credit Designation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum
The many variations of clinical depression and how to treat them Read More »
I enjoyed being a new mom. Sure, there were times during those first weeks when I felt completely overwhelmed and would have bouts of tears. But, in general, I bounced back pretty quickly and managed to keep the baby blues at bay most of the time. The baby blues are common, and a very unscientific
Health Fusion: Feeling blue after baby could be postpartum depression Read More »
Facebook Twitter Instagram Submit Tips for Investigations Newsletters Contact Us WTVJ Public Inspection File WTVJ Accessibility WTVJ Employment Infromation FCC Applications TERMS OF SERVICE Advertise with us Send Feedback Privacy Policy Do Not Sell My Personal Information CA Notice AdChoices Copyright © 2021 NBCUniversal Media, LLC. All rights reserved
Next Tropical Depression Could Be Named as Soon as Thursday – NBC 6 South Florida Read More »
MINDCURE will distribute these protocols to therapists through iSTRYM, its digital therapeutics platform. This milestone in protocol development unlocks the company’s protocol distribution platform in time for iSTRYM’s clinical MVP launch in Q3 2021. VANCOUVER, BC, June 17, 2021 /PRNewswire/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader
Top Players Covered in the Anxiety Disorders and Depression Treatment Market Research Report are Bristol-Myers Squibb (New York, U.S), Johnson & Johnson (New Jersey, U.S), Merck & Co. Inc. (New Jersey, U.S), H. Lundbeck A/S (Denmark, Europe), AstraZeneca (Cambridge, U.K), Eli Lilly and Company (Indiana, U.S), GlaxoSmithKline plc (Brentford, U.K), Pfizer Inc. (New York, U.S)